• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : IgA Nephropathy

IgA Nephropathy - 15 Studies Found

Completed : The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease
: Primary IgA Nephropathy
: 2012-07-25
:
  • Drug: NEFECON All patients wil

Completed : Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy
: IgA Nephropathy
: 2007-10-29
:
  • Drug: supportive therapy with: ACE-inhibitor / ARB / Statin

Completed : Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers
: IgA Nephropathy
: 2010-11-08
: Drug: Calcitriol Calcitriol(1,25-dihydroxycholecalciferol, vitamin D3 analog)0.25 μg per day
Completed : Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy
: IgA Nephropathy
: 2016-11-24
:
  • Drug: Mycophenolate Mofetil le

Completed : Multicenter Study Evaluating the Performance of the Assay of Anti-hinge Region Antibodies in the Diagnosis of Progressive Forms of IgA Nephropathy
: IgA Nephropathy
: 2015-08-17
: Biological: blood sample dosage of anti-hinge region antibodies
Completed : The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy
: IgA Nephropathy
: 2011-10-07
: Drug: Prednisone or Prednisolone daily single dose of 1mg/kg (maximum 80mg) or alternate day single dose
Recruiting : Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy
: Primary IgA Nephropathy
: 2016-04-30
:
  • Drug: Hydroxychloroquine Sulfate

Completed : Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A Nephropathy
: IgA Nephropathy
: 2007-10-25
: Drug: Omega-3 fatty acid ethylester90 Dosage form :1g soft capsule Dosage : two capsules, twice a day.
Completed : Probiotics in IgA Nephropathy
: IgA Nephropathy
: 2013-01-16
:
  • Dietary Supplement: ProTectis
  • Dietary Supp

Completed : Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy
: IgA Nephropathy
: 2025-07-31
: Period A (12 Weeks) - Film-coated tablet, Washout Period: 12 weeks, Period B (24 Weeks) - Placebo
Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.